Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.36 |
| ▸ | GAA | P10253 | 5/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14720912 | 0.85 | KMT2A (0.44) | KMT2AALDH1A1KDM4EGAAMAPT | |
| SCHEMBL14720950 | 0.84 | L3MBTL1 (0.37) | KMT2AALDH1A1KDM4EGAAMAPT | |
| SCHEMBL14721258 | 0.83 | ALDH1A1 (0.36) | KMT2AALDH1A1KDM4EGAAMAPT | |
| SCHEMBL2367316 | 0.79 | FFAR1 (0.35) | KMT2AALDH1A1KDM4EGAAMAPT | |
| SCHEMBL2367405 | 0.76 | PPIB (0.34) | KMT2AALDH1A1KDM4EGAAMAPT | |
| SCHEMBL8209372 | 0.73 | KMT2A (0.62) | KMT2AALDH1A1KDM4EGAAMAPT | |
| SCHEMBL14720800 | 0.69 | MEN1 (0.35) | KMT2AALDH1A1MAPTMEN1TSHR | |
| SCHEMBL10367552 | 0.69 | ACACB (0.37) | — | |
| SCHEMBL14720808 | 0.67 | L3MBTL1 (0.41) | KMT2AALDH1A1KDM4EGAAMAPT | |
| SCHEMBL5326532 | 0.67 | APP (0.42) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2753674-B1 | LUMINESCENT LANTHANIDE CHELATES HAVING THREE CHROMOPHORES AND THEIR USE | DHR FINLAND OY (FI) | 2016-02-10 | — | — | EP | disclosed |
| US-20130210165-A1 | Luminescent Lanthanide Chelates Having Three Chromophores and Their Use | DHR FINLAND OY (FI) | 2013-08-15 | — | — | US | disclosed |
| WO-2013026790-A9 | LUMINESCENT LANTHANIDE CHELATES HAVING THREE CHROMOPHORES AND THEIR USE | DHR FINLAND OY (FI) | 2013-05-23 | — | — | WO | disclosed |
| WO-2013026790-A1 | LUMINESCENT LANTHANIDE CHELATES HAVING THREE CHROMOPHORES AND THEIR USE | DHR FINLAND OY (FI) | 2013-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130210165-A1 | Luminescent Lanthanide Chelates Having Three Chromophores and Their Use | GLB1, SSB, LGALS3BP | KMT2A 4022/4885ALDH1A1 3095/4885KDM4E 1897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.